Developments of subunit and VLP vaccines against influenza A virus. (Q38017605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

title

Developments of subunit and VLP vaccines against influenza A virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

influenza A virus

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Ma-ping Deng

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

Hua-lin Wang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

Fei Deng

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

publication date

9 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

145-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

FluBlok, a next generation influenza vaccine manufactured in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

FluBlok, a recombinant hemagglutinin influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Production of a novel influenza vaccine using insect cells: protection against drifted strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Influenza and the challenge for immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

A "universal" human influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Influenza virus-like particles as a new tool for vaccine immunogenicity testing: Validation of a neuraminidase neutralizing antibody assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

The annual production cycle for influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Changing perspective on immunization against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Protection of mice with recombinant influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Emergence and pandemic potential of swine-origin H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

The M2 proton channels of influenza A and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Virus-like particles in vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Comparative study of influenza virus replication in Vero and MDCK cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12250-012-3241-1

Evolution and ecology of influenza A viruses

21 January 2018

1 reference

12 December 2020

Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine

1 reference

12 December 2020

Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees

1 reference

12 December 2020

Cell-based protein vaccines for influenza

1 reference

12 December 2020

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

1 reference

12 December 2020

Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication

1 reference

12 December 2020

Managing influenza in older patients

1 reference

12 December 2020

10.1007/S12250-012-3241-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 February 2020

1018651780

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684468 AND SRC:MED&resulttype=core&format=json